Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies-Reference-Cited by-同舟云学术

Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies

Published:2006-05 Issue:2 Volume:22 Page:265-273
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Barrachina Marta,Castaño Esther,Dalfó Esther,Maes Tamara,Buesa Carlos,Ferrer Isidro

Publisher

Elsevier BV

Subject

Neurology

Reference48 articles.

1. Is the PARK5 I93M mutation a cause of Parkinson's disease with cognitive deficits and cortical Lewy Pathology? Abstracts 16th International Congress on Parkinson's Disease and Related Disorders, Berlin, June, 2005;Auburger;Parkinsonism Rel. Disord.,2005

2. Chipping away at the chip bias: RNA degradation in microarray analysis;Auer;Nat. Genet.,2003

3. The proteasome;Botchler;Annu. Rev. Biophys. Biomol. Struct.,1999

4. Braak, H., Braak, E., 1999. Temporal sequence of Alzheimer's disease related pathology. In: Peters, A., and Morrison, J.H. (Eds.), Neurodegenerative and age-related changes in structure and function of cerebral cortex. Kluwer Academic/Plenum Publishers. New York, Boston, Dordrecht, London, Moscow, pp. 475–512.

5. Staging of brain pathology related to sporadic Parkinson's disease;Braak;Neurobiol. Aging,2003

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dementia with Lewy Bodies: Genomics, Transcriptomics, and Its Future with Data Science;Cells;2024-01-25

2. Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson’s Disease;International Journal of Molecular Sciences;2024-01-21

3. Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives;Cells;2023-02-17

4. The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease;NeuroMolecular Medicine;2023-02-05

5. From protein biomarkers to proteomics in dementia with Lewy Bodies;Ageing Research Reviews;2023-01